Transactions in Connection with Share Buy-back Program Genmab
29 avr. 2024 04h24 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; April 29, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Transactions in Connection with Share Buy-back Program Genmab
22 avr. 2024 03h30 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; April 22, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
16 avr. 2024 06h24 HE
|
Genmab A/S
Company Announcement Net sales of DARZALEX® in the first quarter of 2024 totaled USD 2,692 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN,...
Transactions in Connection with Share Buy-back Program Genmab
15 avr. 2024 04h07 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; April 15, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Transactions in Connection with Share Buy-back Program
08 avr. 2024 05h44 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; April 8, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion...
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
03 avr. 2024 01h34 HE
|
Genmab A/S
Company Announcement Genmab to acquire ProfoundBio for USD 1.8 billion in cash Acquisition will give Genmab worldwide rights to three candidates in clinical development, including rinatabart...
Transactions in Connection with Share Buy-back Program
02 avr. 2024 03h24 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; April 2, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Transactions in Connection with Share Buy-back Program
25 mars 2024 09h31 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; March 25, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Completion of share buy-back program
18 mars 2024 05h49 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; March 18, 2024 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on March 15, 2024 On February 14, 2024, Genmab...
Genmab Announces Initiation of Share Buy-Back Program
15 mars 2024 08h16 HE
|
Genmab A/S
Company Announcement Repurchase of up to DKK 3.5 billion worth of sharesCompletion expected no later than December 16, 2024 COPENHAGEN, Denmark; March 15, 2024 – Genmab A/S (Nasdaq: GMAB) announced...